Prochlorperazine Maleate Intramuscular (Im) And Intravenous (Iv) Injection 5 mg/mL (1 mL ampoules) Suppliers & Bulk Manufacturers

Available Forms: Intramuscular (IM) and intravenous (IV) injection

Available Strengths: 5 mg/mL (1 mL ampoules)

Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®

Category: Antipsychotropic Drugs

Prochlorperazine maleate is a dopamine D2 receptor antagonist that works by blocking dopamine in the brain’s chemoreceptor trigger zone. Administered intramuscularly or intravenously, it is used to control severe nausea and vomiting, including postoperative and chemotherapy-induced cases, and also manages acute psychotic episodes and agitation. Prochlorperazine Maleate IM/IV injection is approved in both the USA and EU for the management of severe nausea, vomiting, and acute psychotic disorders. In the U.S., the FDA lists it under prescription-only medications with boxed warnings regarding use in elderly patients with dementia-related psychosis. In the EU, it is regulated by national authorities and requires a valid prescription. Both regions emphasize careful monitoring due to potential extrapyramidal side effects. For global buyers and B2B partners, detailed regulatory support and compliant sourcing options are available—explore more on pharmatradz.com.

Product Description:

Prochlorperazine Maleate is a versatile phenothiazine-class medication used to manage nausea, vomiting, vertigo, schizophrenia, and migraines. Widely marketed in the US as Compazine® and in the EU as Stemetil® and Buccastem®, it is available in multiple dosage forms including oral tablets (5 mg, 10 mg), buccal tablets (3 mg), rectal suppositories (25 mg), and injections (5 mg/mL). Its broad therapeutic use makes it a valuable molecule in both hospital and retail supply chains. Source Prochlorperazine Maleate APIs and finished dosage forms directly from verified manufacturers and suppliers at Pharmatradz.com—your global B2B pharma network.